Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Panov, Alexander V., Gutekunst, Claire-Anne, Leavitt, Blair R., Hayden, Michael R., Burke, James R., Strittmatter, Warren J., Greenamyre, J. Timothy·2002·Nature Neuroscience

DOI 10.1038/nn884

Cited by (1,000)

Items 701–800 of 1,000

Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells
Ferdinando Squitieri, Vittorio Maglione, Sara Orobello, Francesco Fornai · 2011 · Journal of Neural Transmission
DISC1 and Huntington's Disease – Overlapping Pathways of Vulnerability to Neurological Disorder?
R. Boxall, D. Porteous, P. Thomson · 2011 · PLoS ONE
Advances in Huntington Disease Drug Discovery: Novel Approaches to Model Disease Phenotypes
Jonathan Bard, Michael D. Wall, Ovadia Lazari, Jamshid Arjomand, Ignacio Muñoz-Sanjuán · 2013 · SLAS DISCOVERY
DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases
Nan Zhang, Brittani Bewick, Jason Schultz, Anjana Tiwari, Robert Krencik, Aijun Zhang, Kaho Adachi, Guangbin Xia, Kyuson Yun, Partha S. Sarkar et al. · 2021 · Neurotherapeutics
Huntington's disease
Raphael M. Bonelli, M. Flint Beal · 2012 · Handbook of clinical neurology
Maladie de Huntington : signalisation intracellulaire et mort neuronale
Sandrine Humbert, Frédéric Saudou · 2005 · Journal de la Société de Biologie
Common Variations in 4p Locus are Related to Male Completed Suicide
Anne Must, Sulev Kõks, Eero Vasar, Gunnar Tasa, Aavo Lang, Eduard Maron, Marika M Väli · 2008 · NeuroMolecular Medicine
Stem Cells Transplantation and Huntington’s Disease
Wooseok Im, Soon‐Tae Lee, Kon Chu, Manho Kim, Jae‐Kyu Roh · 2009 · International Journal of Stem Cells
RNA Aptamers Rescue Mitochondrial Dysfunction in a Yeast Model of Huntington’s Disease
Kinjal A. Patel, Rajeev Kumar Chaudhary, Ipsita Roy · 2018 · Molecular Therapy — Nucleic Acids
Do BDNF and NT‐4/5 exert synergistic or occlusive effects on corticostriatal transmission in a male mouse model of Huntington's disease?
Francisco Miguel Torres-Cruz, Ernesto Mendoza, Israel César Vivar‐Cortés, Francisco García‐Sierra, Elizabeth Hernández · 2019 · Journal of Neuroscience Research
Effects of Anthocyanins on CAG Repeat Instability and Behaviour in Huntington’s Disease R6/1 Mice
Linda Møllersen, Olve Moldestad, Alexander D. Rowe, Anja Bjølgerud, Ingunn Holm, Linda Tveterås, Arne Klungland, Lars Retterstøl · 2016 · PLoS Currents
Mutant huntingtin fails to directly impair brain mitochondria
James Hamilton, Tatiana Brustovetsky, Nickolay Brustovetsky · 2019 · Journal of Neurochemistry
Oxidation Promotes Distinct Huntingtin Aggregates in the Presence and Absence of Membranes
Adewale Adegbuyiro, Alyssa R. Stonebraker, Faezeh Sedighi, Caleb K. Fan, Breanna L. Hodges, Peng Li, Stephen J. Valentine, Justin A. Legleiter · 2022 · Biochemistry
Mitochondrial degradation of amyloidogenic proteins — A new perspective for neurodegenerative diseases
Janin Lautenschläger, Gabriele S. Kaminski Schierle · 2019 · Progress in Neurobiology
Macromolecular crowding in solution alters huntingtin interaction and aggregation at interfaces
Sharon E. Groover, Adewale Adegbuyiro, Caleb K. Fan, Breanna L. Hodges, Maryssa A. Beasley, Katelyn Taylor, Alyssa R. Stonebraker, Chathuranga Siriwardhana, Justin A. Legleiter · 2021 · Colloids and Surfaces B Biointerfaces
Current understanding on the pathogenesis of polyglutamine diseases
Xiaohui He, Fang Lin, Zheng‐Hong Qin · 2010 · Neuroscience Bulletin
Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid
Tatiana Rosado Rosenstock, Vanessa Costhek Abílio, Roberto Frussa‐Filho, Beatriz Hitomi Kiyomoto, Soraya Soubhi Smaili · 2008 · Pharmacology Biochemistry and Behavior
Phosphomimetic Mutations Impact Huntingtin Aggregation in the Presence of a Variety of Lipid Systems
Sharon E. Groover, Maryssa A. Beasley, Visvanathan Ramamurthy, Justin A. Legleiter · 2020 · Biochemistry
Mutant huntingtin goes straight to the heart
Elena F. Cattaneo, Paolo Calabresi · 2002 · Nature Neuroscience
Polyglutamine tract‐binding protein‐1 dysfunction induces cell death of neurons through mitochondrial stress
Shigeki Marubuchi, Yo‐ichi Wada, Tomohiro Okuda, Yukiko Hara, Mei‐Ling Qi, Masataka Hoshino, Masaya Nakagawa, Ichiro Kanazawa, Hitoshi Okazawa · 2005 · Journal of Neurochemistry
High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington’s disease expansion mutation carriers shows normal mitochondrial respiratory function
Eva Buck, Martina Zügel, Uwe Schümann, Tamara Merz, Anja Maria Gumpp, Anke Witting, Jürgen Michael Steinacker, G. Bernhard Landwehrmeyer, Patrick Weydt, Enrico Calzia et al. · 2017 · PLoS ONE
Retinoic acid receptor beta protects striatopallidal medium spiny neurons from mitochondrial dysfunction and neurodegeneration
Marion Ciancia, Monika Rataj-Baniowska, Nicolas Zinter, Vito Antonio Baldassarro, Valérie Fraulob, Anne‐Laure Charles, Rosana Álvarez, Shin‐ichi Muramatsu, Ángel R. de Lera, Bernard Gény et al. · 2022 · Progress in Neurobiology
Late onset vascular dysfunction in the R6/1 model of Huntington’s disease
Awahan Rahman, Mari Ekman, Yulia Shakirova, Kristina E. Andersson, Matthias Mörgelin, Jonas Sten Erjefalt, Patrik Brundin, Jiayi Li, Karl Swärd · 2012 · European Journal of Pharmacology
Age-associated chromatin relaxation is enhanced in Huntington’s disease mice
Myungsun Park, Byungkuk Min, Kyuheum Jeon, Sunwha Cho, Jung Sun Park, Jisun Kim, Jeha Jeon, Jinhoi Song, Seokho Kim, Sangkyun Jeong et al. · 2017 · Aging
Investigating the interactions of the first 17 amino acid residues of Huntingtin with lipid vesicles using mass spectrometry and molecular dynamics
Ahmad Kiani Karanji, Maryssa A. Beasley, Daud Sharif, Ali Ranjbaran, Justin A. Legleiter, Stephen J. Valentine · 2019 · Journal of Mass Spectrometry
Antioxidants cannot suppress the lethal phenotype of a Drosophila melanogaster model of Huntington’s disease
Sepehr Bahadorani, Arthur J. Hilliker · 2008 · Genome
Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target
Melissa Scholefield, Stefano Patassini, Jingshu Xu, Garth J. S. Cooper · 2023 · EBioMedicine
Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases
Ashley L. Reed, Wayne Mitchell, Andrei T. Alexandrescu, Nathan N. Alder · 2023 · Frontiers in Physiology
Poration of mitochondrial membranes by amyloidogenic peptides and other biological toxins
Neville Vassallo · 2024 · Journal of Neurochemistry
Mutant huntingtin does not cross the mitochondrial outer membrane
James Hamilton, Tatiana Brustovetsky, Rajesh Khanna, Nickolay Brustovetsky · 2020 · Human Molecular Genetics
Membrane Interactions Accelerate the Self-Aggregation of Huntingtin Exon 1 Fragments in a Polyglutamine Length-Dependent Manner
Arnaud Marquette, Christopher Aisenbrey, Burkhard Bechinger · 2021 · International Journal of Molecular Sciences
Empowering Melatonin Therapeutics with Drosophila Models
Cassandra Millet-Boureima, Caroline C. Ennis, Jurnee Jamison, Shana McSweeney, Anna Park, Chiara Gamberi · 2021 · Diseases
The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
Michael Klonarakis, Maya De Vos, Emma K. Woo, Liam T. Ralph, Jonathan S. Thacker, Joana Gil‐Mohapel · 2022 · Neuroscience & Biobehavioral Reviews
ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line
Yideng Liang, Haibing Jiang, Tamara Ratovitski, Chunfa Jie, Masayuki Nakamura, Ricky R. Hirschhorn, Xiaofang Wang, Wanli Wei Smith, Tsonwin Hai, Michelle A. Poirier et al. · 2009 · Brain Research
4‐hydroxy tempo improves mitochondrial and neurobehavioral deficits in experimental model of H untington's disease
Rajat Sandhir, Namita Mahajan, Arpit Mehrotra, Aanchal Aggarwal, Aditya Sunkaria · 2014 · Synapse
Huntington’s Disease Pathogenesis: Mechanisms and Pathways
Albert R. La Spada, Patrick Weydt, Victor V. Pineda · 2011 · Europe PMC (PubMed Central)
Identification of Novel Therapeutic Targets for Polyglutamine Diseases That Target Mitochondrial Fragmentation
Annika Traa, Emily Machiela, Paige D. Rudich, Sonja K. Soo, Megan M. Senchuk, Jeremy M. Van Raamsdonk · 2021 · International Journal of Molecular Sciences
Mitochondrial distribution violation and nuclear indentations in neurons differentiated from iPSCs of Huntington's disease patients
Evgeny D. Nekrasov, С. Л. Киселев · 2018 · Journal of Stem Cells and Regenerative Medicine
Hprt (CAG)146 mice: Age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
Sara J. Tallaksen‐Greene, Jared M. Ordway, Andrew B. Crouse, Walker S. Jackson, Peter J. Detloff, Roger L. Albin · 2003 · The Journal of Comparative Neurology
Synaptic mitochondria in aging and neurodegenerative diseases: Functional decline and vulnerability
Cicali, Karina A., Torres, Angie K., Tapia-Rojas, Cheril · 2026 · Neural Regeneration Research
Short-chain fatty acids in Huntington's disease: Mechanisms of action and their therapeutic implications
Mohamed Jamal Saadh, Hanan Hassan Ahmed, Radhwan Abdul Kareem, Gaurav V. Sanghvi, Subbulakshmi Ganesan, Mohit Agarwal, Parjinder Kaur, Waam Mohammed Taher, Mariem Alwan, Mahmood Jasem Jawad et al. · 2025 · Pharmacology Biochemistry and Behavior
Challenges of Huntington's disease and quest for therapeutic biomarkers
Eva Kotrčová, Karla Jarkovská, Ivona Valeková, M. (Martina) Žižková, Jan Motlík, Suresh Jivan Gadher, Hana Kovářová · 2014 · PROTEOMICS - CLINICAL APPLICATIONS
Mitochondrial Biology and the Identification of Biomarkers of Huntington’s Disease
Andreas Neueder, Michael Orth · 2020 · Neurodegenerative Disease Management
Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains
Pritika J. Narayan, Suzanne J. Reid, Emma L. Scotter, Ailsa L. McGregor, Nasim F. Mehrabi, Malvindar K. Singh‐Bains, Michelle Glass, Richard L. M. Faull, Russell G. Snell, Mike Dragunow · 2020 · Neurobiology of Disease
Involvement of CRMP2 in Regulation of Mitochondrial Morphology and Motility in Huntington’s Disease
Tatiana Brustovetsky, Rajesh Khanna, Nickolay Brustovetsky · 2021 · Cells
Mitochondrial Dysfunction in Repeat Expansion Diseases
Alberto Giménez-Bejarano, Eva Alegre-Cortés, Sokhna M. S. Yakhine-Diop, Patricia Gómez‐Suaga, José Manuel Fuentes · 2023 · Antioxidants
Metabolic and electrophysiological changes in the basal ganglia of transgenic Huntington's disease rats
Rinske Vlamings, Abdelhamid Benazzouz, Jonathan Chetrit, Marcus L.F. Janssen, Ramazan Kozan, Veerle E. R. M. Visser-Vandewalle, Harry W.M. Steinbusch, Stephan von Hörsten, Yasin Temel · 2012 · Neurobiology of Disease
Potential therapeutic targets in polyglutamine-mediated diseases
Masahisa Katsuno, Hirohisa Watanabe, Masahiko Yamamoto, Gen Sobue · 2014 · Expert Review of Neurotherapeutics
Investigation of tRNALeu/Lys and ATPase 6 Genes Mutations in Huntington’s Disease
Sadaf Kasraie, Massoud Houshmand, Mohammad Mehdi Banoei, Solmaz Etemad, Mehdi Shafa Shariat Panahi, Parvin Shariati, Mohammad Ali Bahar, Mostafa Moin · 2008 · Cellular and Molecular Neurobiology
Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study
Marcus P.J. van Diemen, Ellen P. Hart, Anthony Abbruscato, Liz Mead, Ilse van Beelen, Sandrin C. Bergheanu, Pieter W. Hameeteman, Emma M. Coppen, Jessica Y. Winder, Matthijs Moerland et al. · 2020 · British Journal of Clinical Pharmacology
Huntingtin proteolysis in Huntington disease
Cheryl Lea Wellington, Lisa Ellerby, Blair R. Leavitt, Sophie Roy, Donald W. Nicholson, Michael R. Hayden · 2003 · Clinical Neuroscience Research
Huntington Disease
Laura A. Wagner, Liliana Menalled, Alexander D. Goumeniouk, Daniela Brunner, Blair R. Leavitt · 2008 · Elsevier eBooks
Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability
David L Blum, Marie‐Christine Galas, Laëtitia Cuvelier, Serge N. Schiffmann · 2003 · Neuroscience Letters
Genetic criteria for Huntington's disease pathogenesis
James F. Gusella, Marcy E. MacDonald · 2006 · Brain Research Bulletin
Promising molecular targets for pharmacological therapy of neurodegenerative pathologies
Маргарита Е. Неганова, Yulia R. Aleksandrova, Vladimir O. Nebogatikov, Sergey G. Klochkov, A. A. Ustyugov · 2020 · Acta Naturae
Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington’s disease
Katerina D. Oikonomou, Elissa J. Donzis, Minh T. N. Bui, Carlos Cepeda, Michael S. Levine · 2021 · Journal of Neurophysiology
Mitochondrial tRNALeu/Lys and ATPase 6/8 Gene Variations in Spinocerebellar Ataxias
Sepideh Safaei, Massoud Houshmand, Mohammad Mehdi Banoei, Mehdi Shafa Shariat Panahi, Shahriar Nafissi, Kazem Parivar, Maryam Rostami, Parvin Shariati · 2008 · Neurodegenerative Diseases
Age-Dependent Biphasic Changes in Ischemic Sensitivity in the Striatum of Huntington's Disease R6/2 Transgenic Mice
Gloria J. Klapstein, Michael S. Levine · 2004 · Journal of Neurophysiology
Disruption of the mitochondrial network in a mouse model of Huntington's disease visualized by in-tissue multiscale 3D electron microscopy
Eva Martin‐Solana, Laura Casado-Zueras, Teobaldo Enrique Torres, Gerardo Fabián Goya, Marı́a Rosario Fernández-Fernández, José‐Jesús Fernández · 2024 · Acta Neuropathologica Communications
Mitochondrial Dynamics in Neurodegenerative Diseases
Jennifer R. Pinnell, Kim Tieu · 2017 · Advances in neurotoxicology
Enhanced Toxicity to the Catecholamine Tyramine in Polyglutamine Transfected SH-SY5Y Cells
Rebecca R. Smith, Edgardo R. Dimayuga, Jeffrey N. Keller, William F. Maragos · 2005 · Neurochemical Research
Skeletal muscle characteristics and mitochondrial function in Huntington's disease patients
Saskia Maria Gehrig, Jens Alexander Petersen, Sebastian Frese, Sandro Manuel Mueller, Violeta Mihaylova, Maria Ligon‐Auer, Carsten Lundby, Marco Toigo, Hans Heinrich Jung · 2017 · Movement Disorders
Nucleocytoplasmic transport of huntingtin and Huntington's disease
Ray Truant · 2003 · Clinical Neuroscience Research
Capturing intracellular Ca 2+ dynamics in computational models of neurodegenerative diseases
Haroon Anwar · 2016 · Drug Discovery Today Disease Models
The Role of Impaired Mitochondrial Transport in the Development of Neurodegenerative Diseases
Alexander V. Blagov, Evgeny E. Borisov, Andrey V. Grechko, Mikhail Aleksandrovich Popov, Vasily N. Sukhorukov, Alexander Nikolaevich Orekhov · 2023 · Journal of Integrative Neuroscience
Cyclin-dependent Kinase 5 and Neurodegenerative Diseases
Mingxue Song, Yalong Qiang, Xiulan Zhao, Fuyong Song · 2024 · Molecular Neurobiology
Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases
Nitu L. Wankhede, Mayur Bhimrao Kale, Mohit D. Umare, Sanket Lokhande, Aman Babanrao Upaganlawar, Pranay Wal, Brijesh Gulabrao Taksande, Milind Janrao Umekar, Prasanna Shama Khandige, Bhupendra Singh et al. · 2024 · Current Pharmaceutical Design
Modulation of mitochondrial function by stem cell-derived cellular components
Tian Liu, Wooseok Im, Soon‐Tae Lee, Jae-Jun Ban, Ye Jin Chai, Mijung Lee, Inhee Mook‐Jung, Kon Chu, Manho Kim · 2014 · Biochemical and Biophysical Research Communications
Physiopathologie de la maladie de Huntington : état des connaissances
Emmanuel Flamand Roze, Sandrine Bétuing, Carole Deyts, Marie Vidailhet, Jocelyne Caboche · 2008 · Revue Neurologique
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Susana Cardoso, Renato X. Santos, Sónia C. Correia, Cristina Carvalho, Xiongwei Zhu, Hyoung‐gon Lee, Gemma Casadesús, Mark A. Smith, George L. Perry, Paula Isabel Moreira · 2009 · Pharmaceuticals
Early apoptotic and late necrotic components associated with altered Ca2+ homeostasis in a peptide‐delivery model of polyglutamine‐induced neuronal death
Mari Suzuki, Tatsuro Koike · 2005 · Journal of Neuroscience Research
Status epilepticus stimulates peroxisome proliferator-activated receptor γ coactivator 1-α/mitochondrial antioxidant system pathway by a nitric oxide-dependent mechanism
Yuxiang Han, Youting Lin, Jingjing Xu, Lili Cao, X.W. Liu, Hongchi Jiang, Z.F. Chi · 2011 · Neuroscience
Update on huntington’s disease
Sarah B. Berman, J. Timothy Greenamyre · 2006 · Current Neurology and Neuroscience Reports
Oligomerization enhances huntingtin membrane activity but is suppressed by covalent crosslinking
Faezeh Sedighi, Adam Skeens, Adewale Adegbuyiro, John Bard, Chathuranga Siriwardhana, Emily Donley, Werner J. Geldenhuys, Justin A. Legleiter · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Epigenetic editing for autosomal dominant neurological disorders
Jennifer J Waldo, Julian A. N. M. Halmai, Kyle D. Fink · 2024 · Frontiers in Genome Editing
Promethazine protects against 3-nitropropionic acid-induced neurotoxicity
Carine Cléren, Noel Ylagan Calingasan, Anatoly A. Starkov, Carine Jacquard, Junya Chen, Emmanuel Brouillet, M. Flint Beal · 2009 · Neurochemistry International
Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines
Walmor C. De Mello, Yamil Gerena, Sylvette Ayala‐Peña · 2017 · Frontiers in Endocrinology
Charge within Nt17 peptides modulates huntingtin aggregation and initial lipid binding events
Alyssa R. Stonebraker, Rachel Hankin, Kathryn L. Kapp, Peng Li, Stephen J. Valentine, Justin A. Legleiter · 2023 · Biophysical Chemistry
A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity
Houda G. Khaled, Hongxuan Feng, Xin Hu, Xin Sun, Wang Zheng, Pan P. Li, Dobrila D. Rudnicki, Wenjuan Ye, Yu‐Chi Chen, Noel T Southall et al. · 2021 · Scientific Reports
From target identification to drug screening assays for neurodegenerative diseases
Chiara Zuccato, Marzia Tartari, Donato Goffredo, Elena F. Cattaneo, Danielle Rigamonti · 2005 · Pharmacological Research
Multi-epitope immunocapture of huntingtin reveals striatum-selective molecular signatures
2025
Generation of Rhesus Macaque Embryos with Expanded CAG Trinucleotide Repeats in the Huntingtin Gene
Junghyun Ryu, John P. Statz, William Chan, Kiana Oyama, Maggie Custer, Martin Wienisch, Richard Chen, Carol B. Hanna, Jon D. Hennebold · 2024 · Cells
Advances in Clinical Therapies for Huntington's Disease and the Promise of Multi‐Targeted/Functional Drugs Based on Clinicaltrials.gov
Chunhui Huang, Xiao Zheng, Sen Yan, Zaijun Zhang · 2024 · Clinical Pharmacology & Therapeutics
The N17 domain of huntingtin as a multifaceted player in Huntington’s disease
Hyun-Ju Cho · 2025 · Frontiers in Molecular Biosciences
Cell Therapy Strategies vs. Paracrine Effect in Huntington’s Disease
Wooseok Im, Manho Kim · 2014 · Journal of Movement Disorders
Oxidative Changes and Possible Effects of Polymorphism of Antioxidant Enzymes in Neurodegenerative Disease
Eva Babušíková, Andrea Evinová, Jozef Hatok, Dušan Dobrota, Jana Jurecekov · 2013 · InTech eBooks
Essential roles of mitochondrial depolarization in neuron loss through microglial activation and attraction toward neurons
Min‐Kyung Nam, Hyun Ah Shin, Ji-Hye Han, Dae-Wook Park, Hyangshuk Rhim · 2013 · Brain Research
Normalization of Calcium Balance in Striatal Neurons in Huntington’s Disease: Sigma 1 Receptor as a Potential Target for Therapy
Nina Kraskovskaya, Безпрозванный Илья Борисович · 2021 · Biochemistry (Moscow)
Mitochondrial Medicine
Douglas C. Wallace, Marie T. Lott, Vincent Procaccio · 2013 · Elsevier eBooks
Mitochondria in Neurodegeneration
Russell Howard Swerdlow · 2011 · Advances in neurobiology
Doença de Huntington
Joana Gil‐Mohapel, Ana Cristina Rego · 2001 · Revista Neurociências
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study
Christopher Francis McNicoll, Jeanne C. Latourelle, Marcy E. MacDonald, Mark Lew, Oksana Suchowersky, Christine Klein, Lawrence I. Golbe, Margery H. Mark, John H. Growdon, G. Frederick Wooten et al. · 2008 · Movement Disorders
Emerging Promise of Phytochemicals in Ameliorating Neurological Disorders
Megala Jayaraman, Parijat Dutta, Sabari Krishnan B. B., Khyati Arora, Diveyaa Sivakumar, Hanumantha Rao Balaji Raghavendran · 2022 · CNS & Neurological Disorders - Drug Targets
Adenosine Receptors in Huntington’s Disease
David L Blum, Alberto Martire, Sylvie Burnouf, Bernard Sablonnière, Pierre Christophe Krystkowiak, Catherine A. Ledent, Luísa Vaqueiro Lopes, Patrizia Popoli · 2012 · Springer eBooks
Polyalanine and Polyglutamine Diseases: Possible Common Mechanisms?
Aida Abu‐Baker, Guy Armand Rouleau · 2006 · Elsevier eBooks
Protein Misfolding and Aggregation: Implications for Mitochondrial Dysfunction and Neurodegeneration
Marthe H. R. Ludtmann, Andrey Y. Abramov · 2016 · Springer eBooks
Pluripotent Stem Cells for Uncovering the Role of Mitochondria in Human Brain Function and Dysfunction
Annika Zink, Josef Priller, Alessandro Prigione · 2018 · Journal of Molecular Biology
Neuronal chloride transporters in neurodegenerative diseases
Li Yang, Nicholas J. Justice · 2020 · Elsevier eBooks
Intergeneration CAG expansion in a Wuhan juvenile-onset Huntington disease family
Yuan Liu, Yan Shen, He Li, Hui Wang, Zhenrong Yang, Yan Chen, Yanping Tang · 2007 · Neuroscience Bulletin
Machado-Joseph Disease / Spinocerebellar Ataxia Type 3
Clvio Nbrega, Lus Pereira de Almei · 2012 · InTech eBooks